Host-Cell Proteins: Implications for Protein-Drug Efficacy - BioProcess InternationalBioProcess International
Por um escritor misterioso
Last updated 15 março 2025

Host cell protein content is often identified as a critical quality attribute and is often used as a benchmark during biologics manufacturing.

Reinventing How Drugs Are Invented - BioProcess InternationalBioProcess International

What are Host Cell Proteins and Its Effect on Biopharmaceutical Development - Creative Proteomics

Page 79 – BioProcess InternationalBioProcess International, Covering the whole development process for the global biotechnology industry

Risk-Assessment Framework for Managing Host-Cell Proteins - BioProcess InternationalBioProcess International

Rapid Estimation of Size-Based Heterogeneity in Monoclonal Antibodies by Machine Learning-Enhanced Dynamic Light Scattering

Exploring sample preparation and data evaluation strategies for enhanced identification of host cell proteins in drug products of therapeutic antibodies and Fc-fusion proteins

Full article: Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development

HCP Enrichment During CGMP Scale-Up - BioProcess InternationalBioProcess International

Ensuring Patient Safety with Host Cell Proteins - BioProcess InternationalBioProcess International

Immunogenicity Predictions in Host Cell Proteins - BioProcess InternationalBioProcess International